We design, prototype, and develop libraries of novel nanomedicines, combining our in-house expertise with that of Eindhoven University of Technology (TU/e). Together with our clients, we design tailored nanoparticles and diverse libraries targeting specific applications, leveraging our advanced knowledge in self-assembled nanoformulations. Our service can also include CMC trajectory design to ensure a smooth path from concept to clinical development.
Our integrated service for nanoparticle design, prototyping, and library development of novel nanomedicines is specifically tailored to meet the unique needs of each client and therapeutic target. Our approach is highly collaborative, bringing together the specialized expertise of our internal team and leading researchers from Eindhoven University of Technology (TU/e). By leveraging TU/e’s in-depth knowledge of self-assembled nanoformulations, we are able to explore and develop a wide range of nanoparticle types and architectures.
This service supports both the custom design of individual nanoparticles and the creation of comprehensive nanoparticle libraries, enabling systematic screening to identify the most promising candidates for a specific application. We work closely with our clients to incorporate their insights and objectives into the design process, ensuring that the final formulations align with therapeutic goals and development strategies.
Our nanoparticle libraries are designed with versatility in mind, enabling systematic exploration and optimization of key parameters such as size, surface chemistry, drug loading, and release profiles. Through a systematic, iterative screening process combined with advanced analytical techniques, we can efficiently generate and refine high-quality, functional nanomedicine candidates.
In addition to consulting and library design, we offer support in developing the Chemistry, Manufacturing, and Controls (CMC) trajectory, helping to plan for scalability and process robustness from the earliest stages. This ensures a smooth progression from laboratory-scale prototypes to clinical-grade materials.